Analyst Ratings for Akero Therapeutics (AKRO)
AKRO Rating Summary
AKRO Price Target Summary
- Highest: $84.00 (Morgan Stanley)
- Lowest: $58.00 (TD Cowen)
- Average: $67.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$67.33 (+23%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
Avg. $ Target:
$67.33 (+23%)
* Over Last 12-Mos
Rating Score: 7.1 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/13/2025 | TD Cowen | Ritu Baral | Downgrade | Hold (Buy) |
58.00 (N/A) |
54.08 (54.74) |
1.22% | Details |
| 10/10/2025 | H.C. Wainwright | Andrew Fein | Downgrade | Neutral (Buy) |
N/A (N/A) |
54.08 (54.74) |
1.22% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
